Analysen zu Novartis AG
| 25.11.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.11.24 | Novartis Hold | Deutsche Bank AG | |
| 22.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.11.24 | Novartis Underweight | Barclays Capital | |
| 21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 21.11.24 | Novartis Buy | UBS AG | |
| 20.11.24 | Novartis Hold | Deutsche Bank AG | |
| 14.11.24 | Novartis Buy | UBS AG | |
| 07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | Novartis Outperform | Bernstein Research | |
| 30.10.24 | Novartis Hold | Deutsche Bank AG | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Outperform | Bernstein Research | |
| 29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 29.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.10.24 | Novartis Hold | Deutsche Bank AG | |
| 02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
| 23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Novartis Kaufen | DZ BANK | |
| 19.07.24 | Novartis Hold | Deutsche Bank AG | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 18.07.24 | Novartis Outperform | Bernstein Research | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 10.07.24 | Novartis Buy | Deutsche Bank AG | |
| 03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Deutsche Bank AG | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | Novartis Underweight | Barclays Capital | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.06.24 | Novartis Buy | Deutsche Bank AG | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.05.24 | Novartis Buy | Deutsche Bank AG | |
| 23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Aktuelle Aktienanalysen
| 16.12.25 | GSK Hold | Deutsche Bank AG | |
| 16.12.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 16.12.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.12.25 | Novartis Buy | Deutsche Bank AG | |
| 16.12.25 | DEUTZ Buy | Warburg Research | |
| 16.12.25 | KION GROUP Buy | UBS AG | |
| 16.12.25 | WACKER CHEMIE Sell | Deutsche Bank AG | |
| 16.12.25 | WACKER CHEMIE Buy | UBS AG | |
| 16.12.25 | K+S Sell | UBS AG | |
| 16.12.25 | Evonik Neutral | UBS AG | |
| 16.12.25 | GEA Buy | UBS AG | |
| 16.12.25 | Daimler Truck Neutral | UBS AG | |
| 16.12.25 | RWE Buy | Deutsche Bank AG | |
| 16.12.25 | LANXESS Sell | UBS AG | |
| 16.12.25 | Nike Outperform | Bernstein Research | |
| 16.12.25 | adidas Outperform | Bernstein Research | |
| 16.12.25 | Fresenius Buy | Jefferies & Company Inc. | |
| 16.12.25 | Fresenius Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | Ferrari Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.12.25 | Airbus Overweight | Barclays Capital | |
| 16.12.25 | Fresenius Overweight | Barclays Capital | |
| 16.12.25 | Ferrari Outperform | RBC Capital Markets | |
| 15.12.25 | arGEN-X Buy | Jefferies & Company Inc. | |
| 15.12.25 | OMV Underweight | Barclays Capital | |
| 15.12.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | arGEN-X Buy | Goldman Sachs Group Inc. | |
| 15.12.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 15.12.25 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
| 15.12.25 | arGEN-X Neutral | UBS AG | |
| 15.12.25 | Nestlé Neutral | UBS AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 15.12.25 | Sanofi Buy | UBS AG | |
| 15.12.25 | Sanofi Overweight | Barclays Capital | |
| 15.12.25 | arGEN-X Overweight | JP Morgan Chase & Co. | |
| 15.12.25 | UBS Buy | Deutsche Bank AG | |
| 15.12.25 | Ströer Buy | Warburg Research | |
| 15.12.25 | Roche Hold | Deutsche Bank AG | |
| 15.12.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 15.12.25 | Polytec kaufen | Warburg Research | |
| 15.12.25 | Raiffeisen | Erste Group Bank | |
| 15.12.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 15.12.25 | TAG Immobilien Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.12.25 | TKMS thyssenkrupp Marine Systems Buy | Deutsche Bank AG | |
| 15.12.25 | PATRIZIA Buy | Deutsche Bank AG | |
| 15.12.25 | Carl Zeiss Meditec Hold | Deutsche Bank AG | |
| 15.12.25 | Nike Neutral | UBS AG | |
| 15.12.25 | Unilever Outperform | Bernstein Research | |
| 15.12.25 | BAT Overweight | Barclays Capital | |
| 15.12.25 | Richemont Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.